
Lakshmi Sarada Channavajjala
Examiner (ID: 456, Phone: (571)272-0591 , Office: P/1611 )
| Most Active Art Unit | 1611 |
| Art Unit(s) | 1615, 1611 |
| Total Applications | 1737 |
| Issued Applications | 722 |
| Pending Applications | 210 |
| Abandoned Applications | 818 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 12022123
[patent_doc_number] => 20170312222
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-02
[patent_title] => 'Taste-Masked Formulations of Raltegravir'
[patent_app_type] => utility
[patent_app_number] => 15/652658
[patent_app_country] => US
[patent_app_date] => 2017-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 10496
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15652658
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/652658 | Taste-Masked Formulations of Raltegravir | Jul 17, 2017 | Abandoned |
Array
(
[id] => 12157194
[patent_doc_number] => 20180028459
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-01
[patent_title] => 'METHOD OF PRODUCING TRANSDERMAL ABSORPTION SHEET'
[patent_app_type] => utility
[patent_app_number] => 15/650981
[patent_app_country] => US
[patent_app_date] => 2017-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 11050
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15650981
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/650981 | METHOD OF PRODUCING TRANSDERMAL ABSORPTION SHEET | Jul 16, 2017 | Abandoned |
Array
(
[id] => 17095469
[patent_doc_number] => 20210283260
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-16
[patent_title] => A CELLULAR SOLID MATERIAL DRUG CARRIER COMPRISING CELLULOSE NANOFIBERS (CNF) WHEREIN THE CELLULAR SOLID MATERIAL COMPRISES CLOSED CELLS
[patent_app_type] => utility
[patent_app_number] => 16/316192
[patent_app_country] => US
[patent_app_date] => 2017-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14082
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16316192
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/316192 | A CELLULAR SOLID MATERIAL DRUG CARRIER COMPRISING CELLULOSE NANOFIBERS (CNF) WHEREIN THE CELLULAR SOLID MATERIAL COMPRISES CLOSED CELLS | Jul 6, 2017 | Abandoned |
Array
(
[id] => 12000103
[patent_doc_number] => 20170304258
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-26
[patent_title] => 'NANOPARTICLE ISOFLAVONE COMPOSITIONS & METHODS OF MAKING AND USING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 15/643201
[patent_app_country] => US
[patent_app_date] => 2017-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 13372
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15643201
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/643201 | Nanoparticle isoflavone compositions and methods of making and using the same | Jul 5, 2017 | Issued |
Array
(
[id] => 13151713
[patent_doc_number] => 10092559
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-10-09
[patent_title] => Abuse resistant pharmaceutical compositions
[patent_app_type] => utility
[patent_app_number] => 15/626268
[patent_app_country] => US
[patent_app_date] => 2017-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 14724
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15626268
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/626268 | Abuse resistant pharmaceutical compositions | Jun 18, 2017 | Issued |
Array
(
[id] => 13076955
[patent_doc_number] => 10058531
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2018-08-28
[patent_title] => Dosage delivery film
[patent_app_type] => utility
[patent_app_number] => 15/611581
[patent_app_country] => US
[patent_app_date] => 2017-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8209
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 115
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15611581
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/611581 | Dosage delivery film | May 31, 2017 | Issued |
Array
(
[id] => 12862381
[patent_doc_number] => 20180179301
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-28
[patent_title] => Method of Preparing Oxidized Starch Haemostatic Material
[patent_app_type] => utility
[patent_app_number] => 15/607561
[patent_app_country] => US
[patent_app_date] => 2017-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4060
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 285
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15607561
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/607561 | Method of preparing oxidized starch haemostatic material | May 28, 2017 | Issued |
Array
(
[id] => 12029476
[patent_doc_number] => 20170319575
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-09
[patent_title] => 'TAMPER-RESISTANT PHARMACEUTICAL COMPOSITIONS OF OPIOIDS AND OTHER DRUGS'
[patent_app_type] => utility
[patent_app_number] => 15/606112
[patent_app_country] => US
[patent_app_date] => 2017-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 13873
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15606112
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/606112 | Tamper-resistant pharmaceutical compositions of opioids and other drugs | May 25, 2017 | Issued |
Array
(
[id] => 11954573
[patent_doc_number] => 20170258724
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-14
[patent_title] => 'METHOD OF BORON NITRIDE NANOPARTICLE FABRICATION FOR ANTITUMOR DRUG DELIVERY'
[patent_app_type] => utility
[patent_app_number] => 15/600510
[patent_app_country] => US
[patent_app_date] => 2017-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3710
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15600510
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/600510 | METHOD OF BORON NITRIDE NANOPARTICLE FABRICATION FOR ANTITUMOR DRUG DELIVERY | May 18, 2017 | Abandoned |
Array
(
[id] => 12143672
[patent_doc_number] => 09877908
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-01-30
[patent_title] => 'Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives'
[patent_app_type] => utility
[patent_app_number] => 15/588485
[patent_app_country] => US
[patent_app_date] => 2017-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13923
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15588485
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/588485 | Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives | May 4, 2017 | Issued |
Array
(
[id] => 17944238
[patent_doc_number] => 20220331255
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-20
[patent_title] => Solid Dosage Form
[patent_app_type] => utility
[patent_app_number] => 16/097112
[patent_app_country] => US
[patent_app_date] => 2017-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33965
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16097112
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/097112 | Solid Dosage Form | Apr 27, 2017 | Abandoned |
Array
(
[id] => 13035377
[patent_doc_number] => 10039801
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-08-07
[patent_title] => Pharmaceutical compositions of water soluble peptides with poor solubility in isotonic conditions and methods for their use
[patent_app_type] => utility
[patent_app_number] => 15/487731
[patent_app_country] => US
[patent_app_date] => 2017-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 29
[patent_no_of_words] => 24389
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15487731
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/487731 | Pharmaceutical compositions of water soluble peptides with poor solubility in isotonic conditions and methods for their use | Apr 13, 2017 | Issued |
Array
(
[id] => 11713533
[patent_doc_number] => 20170182032
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-29
[patent_title] => 'ABUSE-DETERRENT PHARMACEUTICAL COMPOSITIONS OF OPIOIDS AND OTHER DRUGS'
[patent_app_type] => utility
[patent_app_number] => 15/457153
[patent_app_country] => US
[patent_app_date] => 2017-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9275
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15457153
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/457153 | ABUSE-DETERRENT PHARMACEUTICAL COMPOSITIONS OF OPIOIDS AND OTHER DRUGS | Mar 12, 2017 | Abandoned |
Array
(
[id] => 14975439
[patent_doc_number] => 10441605
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-10-15
[patent_title] => Oral cholestyramine formulation and use thereof
[patent_app_type] => utility
[patent_app_number] => 15/449781
[patent_app_country] => US
[patent_app_date] => 2017-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 6
[patent_no_of_words] => 10168
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 169
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15449781
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/449781 | Oral cholestyramine formulation and use thereof | Mar 2, 2017 | Issued |
Array
(
[id] => 14975437
[patent_doc_number] => 10441604
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-10-15
[patent_title] => Cholestyramine pellets and methods for preparation thereof
[patent_app_type] => utility
[patent_app_number] => 15/449645
[patent_app_country] => US
[patent_app_date] => 2017-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4772
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 137
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15449645
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/449645 | Cholestyramine pellets and methods for preparation thereof | Mar 2, 2017 | Issued |
Array
(
[id] => 12724234
[patent_doc_number] => 20180133245
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-17
[patent_title] => Impact of electrolytes on tumors and various diseases
[patent_app_type] => utility
[patent_app_number] => 15/449807
[patent_app_country] => US
[patent_app_date] => 2017-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 228
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15449807
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/449807 | Impact of electrolytes on tumors and various diseases | Mar 2, 2017 | Abandoned |
Array
(
[id] => 14697495
[patent_doc_number] => 10376469
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-08-13
[patent_title] => Microspheres containing therapeutic agents and related methods of use
[patent_app_type] => utility
[patent_app_number] => 15/436451
[patent_app_country] => US
[patent_app_date] => 2017-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9634
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15436451
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/436451 | Microspheres containing therapeutic agents and related methods of use | Feb 16, 2017 | Issued |
Array
(
[id] => 13925827
[patent_doc_number] => 20190046429
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-14
[patent_title] => DERMAL FILLER COMPOSED OF MACROPOROUS CHITOSAN MICROBEADS AND CROSS-LINKED HYALURONIC ACID
[patent_app_type] => utility
[patent_app_number] => 16/077341
[patent_app_country] => US
[patent_app_date] => 2017-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9705
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16077341
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/077341 | DERMAL FILLER COMPOSED OF MACROPOROUS CHITOSAN MICROBEADS AND CROSS-LINKED HYALURONIC ACID | Feb 8, 2017 | Abandoned |
Array
(
[id] => 11647858
[patent_doc_number] => 20170143759
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-05-25
[patent_title] => 'PHARMACEUTICAL FORMULATIONS OF NITRITE AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/399208
[patent_app_country] => US
[patent_app_date] => 2017-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 20158
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15399208
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/399208 | PHARMACEUTICAL FORMULATIONS OF NITRITE AND USES THEREOF | Jan 4, 2017 | Abandoned |
Array
(
[id] => 12252962
[patent_doc_number] => 09925091
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-03-27
[patent_title] => 'Combination SIS and vacuum bandage and method'
[patent_app_type] => utility
[patent_app_number] => 15/398419
[patent_app_country] => US
[patent_app_date] => 2017-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 5
[patent_no_of_words] => 4475
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 147
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15398419
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/398419 | Combination SIS and vacuum bandage and method | Jan 3, 2017 | Issued |